Nile tilapia (Oreochromis niloticus) has always been considered more resistant to diseases compared to other fish species. However, in recent decades, this fish species has also been susceptible to many bacterial, fungal, parasitic, and nutritional diseases. In Brazil, streptococcosis is one of the main diseases that affect tilapia and has caused many economic losses. A resistance test was conducted with 93 tilapia of four varieties (UFLA strain and three commercial varieties: SC1, SC2, and SC3) to evaluate resistance to experimental inoculation with Streptococcus agalactiae. Each variety was distributed in five aquariums, with nine specimens of the same variety. Among the five aquariums, four housed fish were intraperitoneally inoculated with 107 CFU/fish of S. agalactiae and one aquarium harbored fish from the control group, which received 0.1 mL of sterile BHI (Brain Heart Infusion). Significant differences were observed in the survival rates accumulated at the end of the experiment (day 15), with values of 22, 36, 36, and 15% for SC1, SC2, SC3, and UFLA, respectively. The UFLA strain presented lower survival than other strains, which did not differ among the 15 days of challenge. These results demonstrate that there are animals with a better response to the resistance test than others.